Dark

CRVS
Corvus Pharmaceuticals, Inc.
stock NASDAQ

At Close

Jun 13, 2025 3:59:55 PM EDT

4.17USD-1.651%(-0.07)765,190

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jun 13, 2025 9:28:30 AM EDT

4.27USD+0.708%(+0.03)106,753

After-hours

Jun 13, 2025 4:00:30 PM EDT

4.19USD+0.263%(+0.01)1,268

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

322.72M

CEO

Richard Miller

Headquarters

Burlingame, California, USA

Industry

Biotechnology

OMER XLV

CRVS Stats

Avg. Vol. 10 Day

915,778

Avg. Vol. 30 Day

1,261,194

Employees

Market Cap

322,724,752

Shares Out.

77,114,636

On/Off Exchange

51%/49%

6 Month Beta

1.07

1 Year Beta

1.21

2 Year Beta

1.44

3 Year Beta

1.13

52 Week Low

1.75

52 Week High

10.00

SMA50

3.58

SMA200

5.31

1 Week

+3.59%

1 Month

+16.90%

3 Month

-7.41%

6 Month

-39.35%

1 Year

+105.15%

2 Year

+68.07%

5 Year

+32.02%

Profile

corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.

CRVS Stock Summary

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) stock price today is $4.17, and today's volume is 765,190. CRVS is down -1.651% today. The 30 day average volume is 1,261,194. CRVS market cap is 322.72M with 77,114,636 shares outstanding.

.dark-mode .qnSzbq{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .qnSzbq{ color: #333333; background-color: white; border: 2px solid #333333; }CRVSCorvus Pharmaceuticals, Inc.stock NASDAQ

CRVS Stock Summary

CRVS
Corvus Pharmaceuticals, Inc.
stock NASDAQ